Replies to post #137 on Repros Therapeutics, Inc. (RPRX)

[spartex]

You should go to RFJ's updates. They came from the secondary prospectus. The only delay I see "the Company anticipates initiating a U.S. Phase 2 trial of Proellex in patients with endometriosis in the third quarter of 2007". Was originally stated as first 1/2 of 2007.

http://www.investorshub.com/boards/read_msg.asp?message_id=16680258